Watermelon and l-Citrulline in Cardio-Metabolic Health: Review of the Evidence 2000–2020 Britt Burton-FreemanMorganne FreemanIndika Edirisinghe Nutrition (K. Petersen, Section Editor) 11 December 2021 Article: 81
Statins and Inflammation Martin SatnyJaroslav A. HubacekMichal Vrablik Statin Drugs (R. Ceska, Section Editor) 01 December 2021 Article: 80
Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors Angela PirilloAlberico L. CatapanoGiuseppe D. Norata Nonstatin Drugs (M. Vrablik, Section Editor) Open access 26 October 2021 Article: 79
Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination Bahar BehrouziJacob A. Udell Cardiovascular Disease and Stroke (J. A. Underberg and J. Newman, Section Editors) 21 October 2021 Article: 78
Differences in the 2020 ESC Versus 2015 ESC and 2014 ACC/AHA Guidelines on the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation Mohammad KeykhaeiHaleh AshrafStefan James Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor) 21 October 2021 Article: 77
Highlights of Cardiovascular Disease Studies Presented at the 2021 European Society of Cardiology Congress Michelle T. LeeDhruv MahttaSalim S. Virani Reviews and New Research Implications (S. Virani, Section Editor) 14 October 2021 Article: 76
Gene-Environment Interactions for Cardiovascular Disease Jaana A. HartialaJames R. HilserHooman Allayee Genetics and Genomics (A. Marian, Section Editor) 14 October 2021 Article: 75
Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful? Klaus G. Parhofer Nonstatin Drugs (M. Vrablik, Section Editor) Open access 14 October 2021 Article: 74